Objective. Lack of adherence with pharmacological therapy is a public health concern that compels tremendous costs for the health care system and the community. To analyse the association between socioeconomic disadvantage and primary non-adherence with medication, and to explore possible mediating effects of trust in health care and lifestyle profile. Design. Cross-sectional population-based study based on data from the Swedish national public health surveys 2004–2005. Participants. The study comprised 13603 men and 18292 women aged 21–84 years who had any contact with a physician at a hospital or primary care centre. Measures. Primary non-adherence with medication based on whether respondents reported that they refrained from purchas-ing ...
Socioeconomic impacts on adherence are understudied, particularly in disadvantaged areas. This study...
Background: Low adherence is a key factor in explaining impaired effectiveness and efficiency in the...
There are persisting socioeconomic differences in cardiovascular diseases, but studies on socioecono...
Objective. Lack of adherence with pharmacological therapy is a public health concern that compels tr...
Objective. Lack of adherence with pharmacological therapy is a public health concern that compels tr...
Introduction Older adults are at high risk of medication-related harm (MRH)[1]. Lower socioeconomic...
Background: Non-concordance with medication remains a major public health problem that imposes a con...
BACKGROUND: Knowledge about the social and economical determinants of prescription is relevant in he...
Polypharmacy and potentially inappropriate drug use (IDU) is a major patient safety and public heal...
This study analyzes the socioeconomic gradient in drug utilization. We use The Swedish Prescribed Dr...
This study uses the Swedish register of prescribed drugs, merged with the Survey of Living Condition...
Medication adherence is a multidimensional phenomenon determined by the interaction of factors of di...
BACKGROUND: The main goal of the health care system in Sweden is good health and health care on equa...
Medication adherence is a multidimensional phenomenon determined by the interaction of factors of di...
The global population is ageing and this demographic change has important implications for the provi...
Socioeconomic impacts on adherence are understudied, particularly in disadvantaged areas. This study...
Background: Low adherence is a key factor in explaining impaired effectiveness and efficiency in the...
There are persisting socioeconomic differences in cardiovascular diseases, but studies on socioecono...
Objective. Lack of adherence with pharmacological therapy is a public health concern that compels tr...
Objective. Lack of adherence with pharmacological therapy is a public health concern that compels tr...
Introduction Older adults are at high risk of medication-related harm (MRH)[1]. Lower socioeconomic...
Background: Non-concordance with medication remains a major public health problem that imposes a con...
BACKGROUND: Knowledge about the social and economical determinants of prescription is relevant in he...
Polypharmacy and potentially inappropriate drug use (IDU) is a major patient safety and public heal...
This study analyzes the socioeconomic gradient in drug utilization. We use The Swedish Prescribed Dr...
This study uses the Swedish register of prescribed drugs, merged with the Survey of Living Condition...
Medication adherence is a multidimensional phenomenon determined by the interaction of factors of di...
BACKGROUND: The main goal of the health care system in Sweden is good health and health care on equa...
Medication adherence is a multidimensional phenomenon determined by the interaction of factors of di...
The global population is ageing and this demographic change has important implications for the provi...
Socioeconomic impacts on adherence are understudied, particularly in disadvantaged areas. This study...
Background: Low adherence is a key factor in explaining impaired effectiveness and efficiency in the...
There are persisting socioeconomic differences in cardiovascular diseases, but studies on socioecono...